Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993196priorityCriticalpatent/ECSP993196A/en
Publication of ECSP993196ApublicationCriticalpatent/ECSP993196A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Se descubre un proceso para la preparación de una composición de isotretinoína micronizada. El proceso se lleva a cabo por micronización de la isotretinoina mientras está suspendida en un vehículo oleoso. Además se descubren las composiciones de isotretinoína micronizada y las formas de dosificación unitaria que contienen las composiciones.A process for the preparation of a micronized isotretinoin composition is discovered. The process is carried out by micronizing the isotretinoin while it is suspended in an oily vehicle. In addition, the micronized isotretinoin compositions and unit dosage forms contained in the compositions are disclosed.
ECSP9931961999-10-291999-10-29
ISOTRETINOIN COMPOSITIONS AND PROCESS FOR ITS PRODUCTION
ECSP993196A
(en)
ANALOG COMPOUNDS OF (1R, CIS) -4- (6-AMINO-9H-PURIN-9-IL) -2-CYCLOPENTENE-1-METHANOL, PROCESS FOR PREPARATION, USE IN THE TREATMENT OF VIRAL INFECTIONS, AND PACKING THAT CONTAINS THEM
Crystalline form e3 of atazanavir bisulfate; pharmaceutical composition comprising it; Useful for the treatment of diseases caused by retroviruses (divisional of the application 1057-05).
Substituted 4-phenyl-tetrahydroisoquinolines, process for their preparation, use thereof as medicaments, in addition to medicaments containing the same
COMPOUNDS DERIVED FROM 3H-QUINAZOLIN-4-ONA, ITS PREPARATION PROCESS, PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND USE IN THE TREATMENT AND PREVENTION OF DISEASES MEDIATED BY MAO-B INHIBITORS, SUCH AS THE DISEASE OF ALZHEIMER AND DEMENCIER
"PIRAZOLO [4,3, e] NOVEDOUS REPLACED DIAZEPINS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, ITS USE AS MEDICINAL PRODUCTS AND PROCESSES TO PREPARE THEM
Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
PHARMACEUTICAL COMPOSITION INCLUDING THE PROGESTERONE RECEIVER ANTAGONIST 11B- (4-ACETILFENIL) -17B-HIDROXI-17 ALFA- (1,1,2,2,2-PENTAFLUOROETIL) -ESTRA-4,9-DIEN-3-ONA AND A PURE ANTIESTROGEN; AND ITS USE TO TREAT A DEPENDENT DISEASE OF H